全文获取类型
收费全文 | 151070篇 |
免费 | 12749篇 |
国内免费 | 4854篇 |
学科分类
医药卫生 | 168673篇 |
出版年
2024年 | 127篇 |
2023年 | 1727篇 |
2022年 | 2633篇 |
2021年 | 5056篇 |
2020年 | 4718篇 |
2019年 | 4895篇 |
2018年 | 4805篇 |
2017年 | 4769篇 |
2016年 | 4931篇 |
2015年 | 4968篇 |
2014年 | 7794篇 |
2013年 | 8757篇 |
2012年 | 7338篇 |
2011年 | 8447篇 |
2010年 | 7362篇 |
2009年 | 7213篇 |
2008年 | 7278篇 |
2007年 | 8378篇 |
2006年 | 7700篇 |
2005年 | 7734篇 |
2004年 | 6796篇 |
2003年 | 6013篇 |
2002年 | 4444篇 |
2001年 | 4412篇 |
2000年 | 3597篇 |
1999年 | 3301篇 |
1998年 | 2243篇 |
1997年 | 1992篇 |
1996年 | 2110篇 |
1995年 | 2108篇 |
1994年 | 1855篇 |
1993年 | 1690篇 |
1992年 | 1446篇 |
1991年 | 1256篇 |
1990年 | 1051篇 |
1989年 | 991篇 |
1988年 | 933篇 |
1987年 | 716篇 |
1986年 | 535篇 |
1985年 | 613篇 |
1984年 | 637篇 |
1983年 | 399篇 |
1982年 | 492篇 |
1981年 | 420篇 |
1980年 | 362篇 |
1979年 | 301篇 |
1978年 | 247篇 |
1977年 | 201篇 |
1976年 | 238篇 |
1975年 | 150篇 |
排序方式: 共有10000条查询结果,搜索用时 218 毫秒
51.
52.
《Vaccine》2021,39(45):6601-6613
AKS-452 is a biologically-engineered vaccine comprising an Fc fusion protein of the SARS-CoV-2 viral spike protein receptor binding domain antigen (Ag) and human IgG1 Fc (SP/RBD-Fc) in clinical development for the induction and augmentation of neutralizing IgG titers against SARS-CoV-2 viral infection to address the COVID-19 pandemic. The Fc moiety is designed to enhance immunogenicity by increasing uptake via Fc-receptors (FcγR) on Ag-presenting cells (APCs) and prolonging exposure due to neonatal Fc receptor (FcRn) recycling. AKS-452 induced approximately 20-fold greater neutralizing IgG titers in mice relative to those induced by SP/RBD without the Fc moiety and induced comparable long-term neutralizing titers with a single dose vs. two doses. To further enhance immunogenicity, AKS-452 was evaluated in formulations containing a panel of adjuvants in which the water-in-oil adjuvant, Montanide™ ISA 720, enhanced neutralizing IgG titers by approximately 7-fold after one and two doses in mice, including the neutralization of live SARS-CoV-2 virus infection of VERO-E6 cells. Furthermore, ISA 720-adjuvanted AKS-452 was immunogenic in rabbits and non-human primates (NHPs) and protected from infection and clinical symptoms with live SARS-CoV-2 virus in NHPs (USA-WA1/2020 viral strain) and the K18 human ACE2-trangenic (K18-huACE2-Tg) mouse (South African B.1.351 viral variant). These preclinical studies support the initiation of Phase I clinical studies with adjuvanted AKS-452 with the expectation that this room-temperature stable, Fc-fusion subunit vaccine can be rapidly and inexpensively manufactured to provide billions of doses per year especially in regions where the cold-chain is difficult to maintain. 相似文献
53.
54.
《Vaccine》2021,39(14):1933-1942
The genetic and antigenic drift associated with the high pathogenicity avian influenza (HPAI) viruses of Goose/Guangdong (Gs/GD) lineage and the emergence of vaccine-resistant field viruses underscores the need for a broadly protective H5 influenza A vaccine. Here, we tested experimental vector herpesvirus of turkey (vHVT)-H5 vaccines containing either wild-type clade 2.3.4.4A-derived H5 inserts or computationally optimized broadly reactive antigen (COBRA) inserts with challenge by homologous and genetically divergent H5 HPAI Gs/GD lineage viruses in chickens. Direct assessment of protection was confirmed for all the tested constructs, which provided clinical protection against the homologous and heterologous H5 HPAI Gs/GD challenge viruses and significantly decreased oropharyngeal shedding titers compared to the sham vaccine. The cross reactivity was assessed by hemagglutinin inhibition (HI) and focus reduction assay against a panel of phylogenetically and antigenically diverse H5 strains. The COBRA-derived H5 inserts elicited antibody responses against antigenically diverse strains, while the wild-type-derived H5 vaccines elicited protection mostly against close antigenically related clades 2.3.4.4A and 2.3.4.4D viruses. In conclusion, the HVT vector, a widely used replicating vaccine platform in poultry, with H5 insert provides clinical protection and significant reduction of viral shedding against homologous and heterologous challenge. In addition, the COBRA-derived inserts have the potential to be used against antigenically distinct co-circulating viruses and future drift variants. 相似文献
55.
《Nutrition, metabolism, and cardiovascular diseases : NMCD》2022,32(2):469-478
Background and aimsThe relationship between hemoglobin glycation index (HGI) and the diagnosis and prognosis of cardiovascular disease (CVD) has been verified by previous studies. However, it remains unknown whether HGI has a predictive effect on subclinical myocardial injury (SC–MI). The purpose of the present study was to explore the relationship between HGI and SC–MI in the general population free from CVD.Methods and resultsThe present study included 6009 participants free of CVD from the third National Health and Nutrition Examination Survey. Binary Logistic regression analysis was used to tested the association between HGI and SC–MI. As results, the HGI was significantly higher in participants with SC–MI compared with those without, and the HGI was positively correlated with SC–MI and other metabolic disorder parameters. Each 1-unit increase of HGI and glycated hemoglobin A1c (HbA1c) was independently associated with higher risk of SC–MI (P < 0.05), while fasting plasma glucose (FPG) was no longer a predictive indicator of SC–MI with the increase of confounding factors [OR (95% CI): 1.001 (0.999–1.003), P = 0.305]. And in the subgroup analysis, HGI, only in participants without diabetes, was independently associated with higher risk of SC–MI, while HbA1c and FPG had no independent predictive role in both diabetic and non-diabetic participants.ConclusionsHGI was a significant predictor of SC–MI in the general population free from CVD. 相似文献
56.
Co-trimoxazole is mainly used as a first-line drug for treatment and prophylaxis against Pneumocystis jiroveci pneumonia. This drug, however, has been reported as the most common causative drug for severe cutaneous adverse reactions (SCARs). This study aimed to extensively elucidate the associations between genetic polymorphisms of HLA class I and genes involved in bioactivation and detoxification of co-trimoxazole on co-trimoxazole-induced SCARS in a large sample size and well-defined Thai SCARs patients. A total of 67 patients with co-trimoxazole-induced SCARs, consisting of 51 SJS/TEN patients and 16 DRESS patients, and 91 co-trimoxazole tolerant controls were enrolled in the study. The results clearly demonstrated that the HLA-B113:01 allele was significantly associated with co-trimoxazole-induced SCARs, especially with DRESS (OR = 8.44, 95% CI = 2.66–26.77, P = 2.94 × 10−4, Pc = 0.0126). Moreover, the HLA-C108:01 allele was significantly associated with co-trimoxazole-induced SJS/TEN in the HIV/AIDS patients with an OR of 8.51 (95% CI = 2.18–33.14, P = 8.60 × 10−4, Pc = 0.0241). None of the genes involved in the bioactivation and detoxification of co-trimoxazole investigated in this study play any major role in the development of all phenotypes of SCARs. 相似文献
57.
58.
目的研究生慧汤对APP/PS1(β-amyloid precursor protein/presenilin 1246E)小鼠海马内β淀粉样前体蛋白(Amyloid precursor protein,APP)代谢产物昼夜表达的影响。方法 将56只雄性APP/PS1双转基因痴呆模型小鼠随机分为4组,分别为:痴呆模型组、褪黑素治疗组(0.78 mg·kg-1·d-1)、生慧汤高剂量组(27.0 g·kg-1·d-1)、生慧汤低剂量组(13.5 g·kg-1·d-1),每组14只;对照组为14只雄性C57BL/6J小鼠,连续给药30天。采用Morris水迷宫检测小鼠学习记忆能力,采用酶联免疫吸附检测(ELISA)检测不同时间段取出的海马组织sAPPα含量。对海马β淀粉样蛋白1-40、β淀粉样蛋白1-42表达进行免疫印迹分析。免疫组化(IHC)检测海马CA1区Aβ1-40蛋白的表达。结果 Morris水迷宫结果表明,与对照组相比,模型组上平台潜伏期明显延长、穿越平台次数明显减少(P<0.01);与模型组相比,生慧汤不同剂量组上平台潜伏期明显缩短(P<0.01、P<0.05),穿越平台次数明显增加(P<0.05)。ELISA结果表明,与对照组相比,模型组的sAPPα总量、各时间段(12:00、24:00)sAPPα含量明显减少(P<0.01);与模型组相比,生慧汤不同剂量组sAPPα总量明显增多(P<0.01、P<0.05),生慧汤高剂量组仅能增加12:00 sAPPα含量(P<0.01),生慧汤低剂量组仅能增加24:00 sAPPα含量(P<0.05)。对照组sAPPα含量具有明显昼夜差异(P<0.01)。模型组sAPPα含量的昼夜差异性消失(P>0.05)。生慧汤高剂量组sAPPα含量具有昼夜差异(P<0.01),生慧汤低剂量组sAPPα含量不具有昼夜差异(P>0.05)。Western blot结果显示,与对照组相比,模型组Aβ1-40、Aβ1-42蛋白表达明显增加(P<0.01);与模型组相比,生慧汤高剂量组Aβ1-40、Aβ1-42蛋白表达减少(P<0.05、P<0.01);生慧汤低剂量组仅能减少Aβ1-40蛋白的表达(P<0.05),对Aβ1-42蛋白表达无影响(P>0.05)。免疫组化结果表明,与对照组相比,模型组Aβ1-40表达明显增加(P<0.01);与模型组相比,生慧汤不同剂量组Aβ1-40表达不同程度减少(P<0.01、P<0.05)。结论 生慧汤能够改善5月龄APP/PS1阿尔茨海默病模型小鼠的学习记忆障碍,其机制可能与恢复海马内APP代谢产物sAPPα的昼夜节律性表达、从而减少Aβ的沉积有关。 相似文献
59.
《Taiwanese journal of obstetrics & gynecology》2022,61(6):1082-1085
ObjectiveWe report a low-grade endometrial stromal sarcoma (ESS) with a novel CDKN1A-JAZF1 fusion gene arising from abdominal wall endometrioma.Case reportA 40-year-old woman presented with a 5.5-cm abdominal wall mass juxtaposed to the postoperative scar of two cesarean sections. Histologically, the tumor exhibited obvious tongue-like protrusions into the surrounding tissue, showed spindle cells with multinodular growth pattern that occasionally rotate around small arteries. Immunohistochemically, the tumor cells were positive for CD10, estrogen receptor (ER), progesterone receptor (PR), negatively stained for smooth muscle actin (SMA), CD117, CyclinD1. In addition, a previously undescribed gene fusion between CDNK1A 5′ end of exon 1(NM_000389.5) and JAZF1 3′ end of exon 5 (NM_175,061,3) was reported in this case.ConclusionThis report of ESS suggesting that rapidly growing abdominal wall masses without menstruation-related should be promptly evaluated and treated aggressively. In addition, we have expanded the molecular landscape of low-grade ESS. 相似文献
60.